Article Text

BIOCHEMICAL MARKERS MAY IDENTIFY PRETERM INFANTS WITH A PATENT DUCTUS ARTERIOSUS AT HIGH RISK OF DEATH OR SEVERE INTRAVENTRICULAR HAEMORRHAGE
  1. A F EL-Khuffash1,2,
  2. D Barry1,
  3. K Walsh2,
  4. P G Davis3,
  5. E J Molloy1,2
  1. 1Department of Neonatology, National Maternity Hospital, Dublin, Ireland,
  2. 2Department of Paediatric Cardiology, Our Lady’s Children Hospital, Crumlin, Ireland,
  3. 3Neonatal Services, Royal Women’s Hospital, Carlton, Australia

Abstract

Background A patent ductus arteriosus (PDA) in preterm infants is associated with an increased risk of intraventricular haemorrhage (IVH) and death. Cardiac troponin T (cTnT) and pro-B-type natriuretic peptide (NTpBNP) are markers of cardiac function and can predict poor outcome in adults.

Aims To determine whether echocardiography and cTnT/NTpBNP levels at 48 h predict death before discharge or severe IVH in preterm infants with a PDA.

Methods Infants born <32 weeks gestation or <1500 g underwent echocardiographic and cTnT/NTpBNP measurements at 12 and 48 h of life. Infants were divided according to their status at discharge: a closed PDA at 48 h, infants with a PDA at 48 h and IVH III/IV and/or death and infants with a PDA at 48 h without IVH III/IV or death.

Results Eighty infants with a median gestation of 28 weeks (interquartile range 26.1–29.5) and birth weight 1.06 kg (0.8–1.21) were included. At 48 h, infants with a PDA and IVH III/IV and/or death had significantly higher median NTpBNP/cTnT levels compared with infants with a PDA without IVH III/IV and/or death and those with spontaneous PDA closure (NTpBNP 9282, 5121, and 740 pmol/l, respectively, p = 0.008 and cTnT 0.66, 0.25, and 0.13 μg/l, respectively, p = 0.027). There were no differences in echocardiographic parameters of PDA size, LA : Ao ratio, left and right ventricular outputs between the PDA groups.

Conclusions NTpBNP and cTnT in conjunction with echocardiography may provide a basis for trials of targeted medical treatment in infants with a PDA.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.